CivaTech Oncology Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Employees
  • 9
Employees
  • Latest Deal Type
  • Debt - PPP
  • Investors
  • 4

CivaTech Oncology General Information

Description

Developer of polymer-based devices intended to bring meaningful improvements to low dose rate brachytherapy. The company's devices are fabricated for specific types of tumors and are used for the treatment of early-stage cancers, enabling users to substantially reduce procedure time and provide homogeneous dose distribution and minimize trauma.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
  • 627 Davis Drive Tech 7
  • Morrisville, NC 27560
  • United States
+1 (919) 000-0000

CivaTech Oncology Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CivaTech Oncology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
18. Debt - PPP 10-Apr-2020 00.000 Completed Generating Revenue
17. Grant 01-Jan-2018 00.00 00.000 Completed Generating Revenue
16. Later Stage VC 20-Dec-2017 0000 00.000 Completed Generating Revenue
15. Debt - General 24-Feb-2017 00.00 Completed Generating Revenue
14. Later Stage VC 16-Dec-2016 00.000 00.00 Completed Generating Revenue
13. Grant 19-Sep-2016 00.00 00.000 Completed Generating Revenue
12. Debt - General 25-May-2016 00.000 Completed Generating Revenue
11. Debt - General 23-Jun-2015 00.000 Completed Generating Revenue
10. Later Stage VC 29-Jul-2014 $1.5M $3.89M Completed Generating Revenue
9. Later Stage VC 04-Jun-2013 $1.1M $2.39M Completed Generating Revenue
To view CivaTech Oncology’s complete valuation and funding history, request access »

CivaTech Oncology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of polymer-based devices intended to bring meaningful improvements to low dose rate brachytherapy. The company
Therapeutic Devices
Morrisville, NC
9 As of 2021
00.000
000000000 - 00.000

000000 0

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliq
00000000000 0000000
Littleton, MA
000 As of 0000
00000
0000000 0000 00000

0000000

pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit
00000000 0000000
Cambridge, United Kingdom
0 As of 0000
00.000
0.000 0000-00-00
0000000000 0 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CivaTech Oncology Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mevion Medical Systems Private Equity-Backed Littleton, MA 000 00000 0000000 0000 00000
0000000 0000000000 Venture Capital-Backed Cambridge, United Kingdom 0 00.000 0000000000 0 00.000
0000000 Formerly VC-backed Oakwood, OH 000 00000 00000000000 00000
0000000 Formerly VC-backed Sunnyvale, CA 000 00000 000000 - 000 00000
0-0000 Venture Capital-Backed Shilat, Israel 00 0000 0000000000 0 0000
You’re viewing 5 of 9 competitors. Get the full list »

CivaTech Oncology Executive Team (7)

Name Title Board Seat Contact Info
Suzanne Babcock Co-Founder, Chief Executive Officer & Executive Chairman
Greg Briley Chief Financial Officer & Advisor
Mark Rivard Ph.D Chief Science Officer
Kristy Perez Vice President, Clinical Programs
You’re viewing 4 of 7 executive team members. Get the full list »

CivaTech Oncology Board Members (7)

Name Representing Role Since
Carlton Midyette CivaTech Oncology Board Member 000 0000
James Beck TrustAtlantic Financial Board Member 000 0000
Robert Greczyn Jr. Self Board Member 000 0000
Suzanne Babcock CivaTech Oncology Co-Founder, Chief Executive Officer & Executive Chairman 000 0000
Tempe Lampe Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

CivaTech Oncology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CivaTech Oncology Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Investors Management Corporation PE/Buyout Minority 000 0000 000000 0
Beechtree Capital Venture Capital Minority 000 0000 000000 0
To view CivaTech Oncology’s complete investors history, request access »